Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection

Clinical trial NCT06406816 · RECRUITING

Trial details

NCT number: NCT06406816
Sponsor: Yongyi Zeng
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma

Start date: 2024-05-06
Primary completion: 2026-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.